Top Markets
Coin of the day
Enzo Biochem, Inc. Enzo Biochem, Inc.

Enzo Biochem, Inc.

ENZ
Clasificación en acciones #28166
Enzo Biochem, Inc. is a diversified enterprise that encompasses diagnostics,... Enzo Biochem, Inc. is a diversified enterprise that encompasses diagnostics, clinical laboratory services, and life sciences. The company's core activities involve the entire process of researching, developing, manufacturing, and commercializing diagnostic and scientific investigation products, drawing upon advancements in genetic engineering, biotechnology, and molecular biology. Its operations are organized into three primary segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products division is responsible for creating, producing, and distributing vital tools and reagents tailored for customers in clinical research, pharmaceutical development, and broader bioscience research. Its extensive product catalog features items such as proteins, antibodies, peptides, small molecules, labeling agents, dyes, and various kits. These offerings provide life science researchers with the means for target identification and validation, content analysis, gene expression studies, nucleic acid detection, protein biochemistry and detection, and cellular analysis. This segment also supplies specialized solutions to scientific experts investigating critical health areas, including cancer, cardiovascular ailments, neurological disorders, metabolic conditions (like diabetes and obesity), endocrine imbalances, infectious and autoimmune diseases, hepatotoxicity, and renal injury. The Clinical Laboratory Services segment delivers a comprehensive spectrum of molecular and other clinical laboratory tests and procedures. These are utilized by physicians in routine patient care to help confirm or establish diagnoses, monitor the effectiveness of treatments or medications, and identify previously undiagnosed medical conditions. This division operates a central, full-service clinical laboratory in Farmingdale, New York, complemented by a network of 30 patient service centers across New York and New Jersey. Additionally, it runs dedicated "STAT" or rapid-response laboratories in New York City and Connecticut, alongside a full-service phlebotomy facility and an internal logistics department. The Therapeutics segment is dedicated to pioneering novel treatment approaches within the fields of gastrointestinal, infectious, ophthalmic, and metabolic diseases. Enzo Biochem distributes its array of products and services through its dedicated internal sales team and an extensive network of distributors, reaching both domestic and international markets. The company was established in 1976 and has its corporate headquarters situated in New York, New York.
Precio por acción
$0.5495
Última sincronización: 2025-05-15
Capitalización bursátil
$28.14M
Cambio (1 día)
4.70%
Cambio (1 año)
0.00%
País
US
Comercio Enzo Biochem, Inc. (ENZ)

Categoría

Ratio P/E de Enzo Biochem, Inc. (ENZ)
Ratio P/E al August 2026 TTM: -0.62
Según los últimos informes financieros y el precio de las acciones de Enzo Biochem, Inc., el P/E actual (TTM) de la empresa es -0.62. Al final de 2023, la empresa tenía un P/E de 3.59.
Historial del ratio P/E de Enzo Biochem, Inc. desde 2000 hasta 2026
Relación P/E al final de cada año
Año Ratio P/E Cambiar
2026 (TTM) -0.62 -72.41%
2024 -2.23 -162.05%
2023 3.59 -168.85%
2022 -5.21 -111.36%
2021 45.87 -1,469.40%
2020 -3.35 78.71%
2019 -1.87 -90.67%
2018 -20.09 -90.00%
2017 -200.84 -3,032.49%
2016 6.85 -111.50%
2015 -59.55 190.81%
2014 -20.48 332.49%
2013 -4.73 219.47%
2012 -1.48 -86.89%
2011 -11.31 43.80%
2010 -7.86 -3.16%
2009 -8.12 -83.50%
2008 -49.20 45.77%
2007 -33.75 27.33%
2006 -26.50 -114.85%
2005 178.44 -370.03%
2004 -66.08 -139.03%
2003 169.30 211.46%
2002 54.36 -45.50%
2001 99.74 -51.07%
2000 203.85 0.00%
Relación P/E para empresas similares o competidores
Empresa P/E Ratio Diferencia del P/E Ratio País
31.59 -5,234.81%
US
35.83 -5,923.48%
US
- -
CN
-227.89 36,937.17%
US
38.69 -6,388.15%
US
¿Cómo leer un P/E ratio?

El ratio Precio/Beneficio (P/E Ratio) mide la relación entre el precio de las acciones de una empresa y sus beneficios por acción.
Un P/E bajo pero positivo indica una empresa con altos beneficios en relación a su valoración actual y que podría estar infravalorada. Una empresa con un P/E negativo alto (cerca de 0) indica fuertes pérdidas en comparación con su valoración.

Las empresas con un P/E superior a 30 o negativo suelen considerarse "acciones de crecimiento", lo que significa que los inversores esperan que crezca o se vuelva rentable en el futuro.

Las empresas con un P/E positivo inferior a 10 suelen considerarse "acciones de valor", lo que significa que ya son muy rentables y no se espera un fuerte crecimiento.